Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
Alexandru GrigoreanRoland BingisserGiuseppe ColucciAndré FrenkBernhard GerberUlrike HeldFrancois MachLucia MazzolaiMarc RighiniThomas RosemannTim SebastianRebecca SpeschaStefan StorteckyStephan WindeckerNils KucherPublished in: Trials (2020)
ClinicalTrials.gov Identifier: NCT04400799 First Posted: May 26, 2020 Last Update Posted: July 16, 2020 FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.